Frank L Jr Jaksch
CIK 1437237 · EXECUTIVE CHAIRMAN OF BOARD · last filed 2025-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
37
Lifetime Open-Market Net
-$1.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAGE | Director | — | $3.45 | — | $0 | 1 | 2025-06-25 |
| Niagen Bioscience, Inc. (CDXC) Delisted | EXECUTIVE CHAIRMAN OF BOARD | 2,356,392 | $7.87 | $18.54M | -$1.08M | 21 | 2024-12-13 |
Recent Filings · Page 4 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-14 | — | Buy (P) | +66,665 | $50.0K | |
| 2011-12-08 | — | Buy (P) | +7,500 | $4.5K | |
| 2011-05-12 | — | Grant (A) | — | $0 | |
| 2010-12-15 | — | Buy (P) | +5,000 | $7.5K | |
| 2010-05-24 | — | Grant (A) | — | $0 | |
| 2010-04-06 | — | Grant (A) | — | $0 | |
| 2008-10-29 | — | Gift (G) | — | $0 |
Showing 31–37 of 37
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.